نتائج البحث - Paul B. Robbins

  • يعرض 1 - 19 نتائج من 19
تنقيح النتائج
  1. 1
    Targeted literature review on use of tumor mutational burden status and programmed cell death ligand 1 expression to predict outcomes of checkpoint inhibitor treatment

    Targeted literature review on use of tumor mutational burden status and programmed cell death ligand 1 expression to predict outcomes of checkpoint inhibitor treatment حسب Tina Krieger, Isobel Pearson, Judith A. Bell, Jim Doherty, Paul B. Robbins

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Use of human tissue to assess the oncogenic activity of melanoma-associated mutations

    Use of human tissue to assess the oncogenic activity of melanoma-associated mutations حسب Yakov Chudnovsky, Amy E. Adams, Paul B. Robbins, Qun Lin, Paul A. Khavari

    منشور في 2005
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    <i>In vivo</i> restoration of laminin 5 β3 expression and function in junctional epidermolysis bullosa

    <i>In vivo</i> restoration of laminin 5 β3 expression and function in junctional epidermolysis bullosa حسب Paul B. Robbins, Qun Lin, Julia B. Goodnough, Hongsheng Tian, Xinjian Chen, Paul A. Khavari

    منشور في 2001
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells

    Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells حسب Paul B. Robbins, Dianne C. Skelton, Xiaojin Yu, Stephanie Halene, Earl H. Leonard, Donald B. Kohn

    منشور في 1998
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells

    Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells حسب Paul B. Robbins, Xiaojin Yu, D M Skelton, Karen Pepper, R M Wasserman, Li Zhu, Donald B. Kohn

    منشور في 1997
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    PD-L1 diagnostic tests: a systematic literature review of scoring algorithms and test-validation metrics

    PD-L1 diagnostic tests: a systematic literature review of scoring algorithms and test-validation metrics حسب Margarita Udall, Maria L. Rizzo, Juliet Kenny, Jim Doherty, SueAnn Dahm, Paul B. Robbins, E.C. Faulkner

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    A Phase I Multi-Arm Dose-Expansion Study of the Anti-Programmed Cell Death-Ligand-1 (Pd-L1) Antibody Medi4736: Preliminary Data

    A Phase I Multi-Arm Dose-Expansion Study of the Anti-Programmed Cell Death-Ligand-1 (Pd-L1) Antibody Medi4736: Preliminary Data حسب Neil H. Segal, Omid Hamid, W. Hwu, Christophe Massard, Marcus O. Butler, Scott Antonia, Andy Blake-Haskins, Paul B. Robbins, X. Li, Jim Vasselli, Samir N. Khleif

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma

    Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma حسب Marlon C. Rebelatto, Anita Midha, Amita Mistry, Constantine Sabalos, Nicole Schechter, Xia Li, Xiaoping Jin, Keith E. Steele, Paul B. Robbins, John A. Blake-Haskins, Jill Walker

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Avelumab in Combination with Axitinib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Results from the Phase 1b VEGF Liver 100 Trial

    Avelumab in Combination with Axitinib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Results from the Phase 1b VEGF Liver 100 Trial حسب Masatoshi Kudo, Kenta Motomura, Yoshiyuki Wada, Yoshitaka Inaba, Yasunari Sakamoto, Masayuki Kurosaki, Yoshiko Umeyama, Yoichi Kamei, Junichiro Yoshimitsu, Yosuke Fujii, Mana Aizawa, Paul B. Robbins, Junji Furuse

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors

    Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors حسب Kathryn C. Arbour, Jarushka Naidoo, Keith E. Steele, Ai Ni, André L. Moreira, Natasha Rekhtman, Paul B. Robbins, Joyson Karakunnel, Andreas Rimner, James Huang, Gregory J. Riely, Matthew D. Hellmann

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation

    Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation حسب Giuseppe Masucci, Alessandra Cesano, Rachael E. Hawtin, Sylvia Janetzki, Jenny Zhang, Ilan R. Kirsch, Kevin K. Dobbin, John Alvarez, Paul B. Robbins, Senthamil R. Selvan, Howard Streicher, Lisa H. Butterfield, Magdalena Thurin

    منشور في 2016
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerations

    Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerations حسب Kevin K. Dobbin, Alessandra Cesano, John Alvarez, Rachael E. Hawtin, Sylvia Janetzki, Ilan R. Kirsch, Giuseppe Masucci, Paul B. Robbins, Senthamil R. Selvan, Howard Streicher, Jenny Zhang, Lisa H. Butterfield, Magdalena Thurin

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study

    HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study حسب Vivek Naranbhai, Mathias Viard, Michael Dean, Stefan Groha, David A. Braun, Chris Labaki, Sachet A. Shukla, Yuko Yuki, Parantu K. Shah, Kevin M. Chin, Megan Wind‐Rotolo, Xinmeng Jasmine Mu, Paul B. Robbins, Alexander Gusev, Toni K. Choueiri, James L. Gulley, Mary Carrington

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial

    Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial حسب Toni K. Choueiri, James Larkin, Sumanta K. Pal, Robert J. Motzer, Brian I. Rini, B. Venugopal, B. Yа. Alekseev, Hideaki Miyake, Gwénaëlle Gravis, Mehmet Asım Bilen, Seetharaman Hariharan, A. Chudnovsky, Keith A. Ching, Xinmeng Jasmine Mu, Mariangela Mariani, Paul B. Robbins, Bo Huang, Alessandra di Pietro, Laurence Albigès

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Hallmarks of Resistance to Immune-Checkpoint Inhibitors

    Hallmarks of Resistance to Immune-Checkpoint Inhibitors حسب Maria Karasarides, Alexandria P. Cogdill, Paul B. Robbins, Michaela Bowden, Elizabeth M. Burton, Lisa H. Butterfield, Alessandra Cesano, Christian Hammer, Cara Haymaker, Christine E. Horak, Heather M. McGee, Anne Monette, Nils-Petter Rudqvist, Christine N. Spencer, Randy F. Sweis, Benjamin G. Vincent, Erik Wennerberg, Jianda Yuan, Roberta Zappasodi, Vanessa M. Hubbard Lucey, Daniel K. Wells, Theresa LaVallee

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial

    Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial حسب Robert J. Motzer, Paul B. Robbins, Thomas Powles, Laurence Albigès, John B.A.G. Haanen, James Larkin, Xinmeng Jasmine Mu, Keith A. Ching, Motohide Uemura, Sumanta K. Pal, B. Yа. Alekseev, Gwénaëlle Gravis, Matthew T. Campbell, Konstantin Penkov, Jae‐Lyun Lee, Hariharan Subramanian, Xiao Wang, Weidong Zhang, Jing Wang, Aleksander Chudnovsky, Alessandra di Pietro, Amber C. Donahue, Toni K. Choueiri

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

    Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma حسب Robert J. Motzer, Konstantin Penkov, John B.A.G. Haanen, Brian I. Rini, Laurence Albigès, Matthew T. Campbell, Balaji Venugopal, Christian Kollmannsberger, Sylvie Négrier, Motohide Uemura, Jae L. Lee, Aleksandr Vasiliev, Wilson H. Miller, Howard Gurney, Manuela Schmidinger, James Larkin, Michael B. Atkins, Jens Bedke, B. Yа. Alekseev, Jing Wang, Mariangela Mariani, Paul B. Robbins, Aleksander Chudnovsky, Camilla Fowst, Hariharan Subramanian, Bo Huang, Alessandra di Pietro, Toni K. Choueiri

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Challenges to Using Big Data in Cancer

    Challenges to Using Big Data in Cancer حسب Shawn M. Sweeney, Hisham K. Hamadeh, Natalie Abrams, Stacey J. Adam, Sara Brenner, Dana E. Connors, Gerard J. Davis, Louis D. Fiore, Susan H. Gawel, Robert L. Grossman, Sean E. Hanlon, Karl Hsu, Gary J. Kelloff, Ilan R. Kirsch, Bill Louv, Deven McGraw, Frank Meng, Daniel Milgram, Robert S. Miller, Emily Morgan, Lata Mukundan, Thomas O’Brien, Paul B. Robbins, Eric H. Rubin, Wendy S. Rubinstein, Liz Salmi, Teilo Schaller, George Shi, Caroline C. Sigman, Sudhir Srivastava

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Case Studies for Overcoming Challenges in Using Big Data in Cancer

    Case Studies for Overcoming Challenges in Using Big Data in Cancer حسب Shawn M. Sweeney, Hisham K. Hamadeh, Natalie Abrams, Stacey J. Adam, Sara Brenner, Dana E. Connors, Gerard J. Davis, Louis D. Fiore, Susan H. Gawel, Robert L. Grossman, Sean E. Hanlon, Karl Hsu, Gary J. Kelloff, Ilan R. Kirsch, Bill Louv, Deven McGraw, Frank Meng, Daniel Milgram, Robert S. Miller, Emily Morgan, Lata Mukundan, Thomas O’Brien, Paul B. Robbins, Eric H. Rubin, Wendy S. Rubinstein, Liz Salmi, Teilo Schaller, George Shi, Caroline C. Sigman, Sudhir Srivastava

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: